discontinued

AR10608PU-N Hepatitis C Virus Nucleocapsid Genotype 1 (1-102)

Search for all "Hepatitis C Virus Nucleocapsid Genotype 1"

0.5 mg / €390.00

Quick Overview

Hepatitis C Virus Nucleocapsid Genotype 1

AR10608PU-N

Product Description for Hepatitis C Virus Nucleocapsid Genotype 1

Hepatitis C Virus Nucleocapsid Genotype 1.
Presentation: Purified

Properties for Hepatitis C Virus Nucleocapsid Genotype 1

Product Category Proteins & Growth Factors
Quantity 0.5 mg
Presentation Purified
Source E. coli
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Proteins (de)

Datasheet Extract

Purity >95.0% pure as determined by 10% PAGE (coomassie staining).
Purification Method: Sepharose-Derived Purification.
Application Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems.
Background HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae.
HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). 
Concentration 1.0 mg/ml
Storage

Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Description
Description:
E.coli derived recombinant. The protein contains the HCV nucleocapsid immunodominant regions.
Specificity: Immunoreactive with sera of HCV- infected individuals.
Format
Buffer System:
50mM Tris, pH 8.0, 5mM EDTA
Purity:
>95.0% pure as determined by 10% PAGE (coomassie staining).
Purification Method: Sepharose-Derived Purification.
State:
Purified
  • LinkedIn